Neumora Therapeutics’ (NMRA) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada
Neumora Therapeutics (NASDAQ:NMRA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by investment analysts at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $4.00 price target on the stock. Royal Bank of Canada’s price objective would suggest a potential upside […]
Neumora Therapeutics (NASDAQ:NMRA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by investment analysts at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $4.00 price target on the stock. Royal Bank of Canada’s price objective would suggest a potential upside […]
